FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

FDA bans use of Lilly, Regeneron COVID drugs due to Omicron

Source: 
Pharmaforum
snippet: 

The FDA has limited the use of COVID-19 antibody therapies developed by Eli Lilly and Regeneron, on the back of data suggesting they have are “highly unlikely” to be effective against the now-dominant Omicron variant.